The need of quality standards in preclinical research is a topic gaining attention in the last years, especially in translational research. The IMI-PainCare consortium have reached out another IMI initiative: European Quality in Preclinical Data (EQIPD; https://quality-preclinical-data.eu/) to collaborate in assessing the study design and data analysis for our studies within subgroups BioPain and TRiPP. This collaboration will ensure equivalent quality standards in preclinical research among the project members, allowing for a successful reproducibility, reducing failure rates and the time and costs associated. IMI-Pain Care welcomes EQIPD to the team and looks forward to the outputs of this collaboration.